Evidence map›Paper›PMID 38784554›Full record

ArticleHeliyon2024

Effects of

Xiaolei Zhang, Yinan Zhao, Yagang Song, Mingsan Miao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Observational
  3. Efficacy ofMetabolism open · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaolei ZhangAcademy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Yinan ZhaoAcademy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Yagang SongAcademy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, 450046, China.
Mingsan MiaoAcademy of Chinese Medical Sciences, Henan University of Chinese Medicine, Zhengzhou, 450046, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and aims: Methods: A comprehensive search was conducted across several databases, including PubMed, EMBASE, Web of Science, and Cochrane Library, from the inception of each database until April 22, 2023. The Hartung-Knapp adjustment was applied to ensure conservative summary estimates with broad confidence intervals. Results: A total of eight trials involving 423 patients with T2DM were included in this study. Compared to the control group, the intake of Conclusions: The findings of this study suggest that

Indexed as

Glycemic indicesLipid profileMeta-analysisMomordica charantiaType 2 diabetes

Identifiers

PMID38784554
PMCPMC11112315

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.